Dr Yamamoto states GcMAF does not have side effects. Our experiences agree: GcMAF has shown no side effects of its own. That’s not surprising – your body expects to have it.
But your rebuilt immune system may in some cases give you minor secondary side effects, but larger side effects with late stages of cancer, and occasionally severe effects with autism, HIV and ME/CFS, as viruses fight back against the rebuilt immune system’s attack.
People’s reactions to a rebuilt immune system are very different – from zero, which is typical, to severe in a minority of cases.
Inside two hours GcMAF will begin to affect your immune system, and (if your immune system is at least partially active) a shot of 0.1ml or more may cause tiredness which usually lasts 3-4 hours. You may feel better than usual for the first 2-3 weeks as the immune system wakes up.
Manifestations of the disease
We need to change our paradigm from the existing one that symptoms are directly due to the pathogen or insult to the understanding that the symptoms and in fact clinical markers are due to the immune response. So instead of believing shingles erupts or herpes erupts or cystitis symptoms erupt when our immunity is depressed, we see these eruptions as an immune activation.
Of course, if there are factors suppressing immune function then these reactions will be ineffective long term. But our routine approach of suppressing symptoms when faced with an “acute illness” is likely promoting chronic problems.
The immune response in autism
GcMAF/VDTP is produced in all higher order animals and is a glycoprotein that the body both needs and expects. Therefore it produces no side effects in humans and any symptoms are the result of an activated immune system – the manifestation of the disease.
If possible these symptoms should be managed accordingly, any attempt to suppress them can lead to prolonged symptoms and therefore discomfort. An extract from Dr Bradstreets paper
“During the first few weeks of treatment, 3 of 40 patients (7.5%) experienced low to moderate rise in body temperature, typically occur-ring 24 to 48 hours after the GcMAF injection and lasting less than 24 hours. Parents were instructed to use ibuprofen only if the temperature exceeded 102° F (approximately 39°C), and two were treated during the first few weeks. By the second month, no patients experienced significant febrile events. Interestingly, during the first 3 weeks, 6 of 40 patients (15%) were observed to have rashes compatible with viral exan¬themas (generally on the trunk and in fine papules more commonly than maculae). Petechiae were not observed. These rashes could represent the manifestation of latent or persistent viral infections interacting with activated macrophages”
Fever as an immune response – good or bad?
Fever is generally measured at about 40 – 40.5c (103 – 104f) and occurs naturally when we are infected by a virus, for example.
Fever is a very effective, and wise, reaction that has developed in all mammals and humans.
Because viruses, bacteria and pathogens multiply rapidly their membranes are thinner than those of naturally occurring cells and the fever weakens the membrane which makes them more vulnerable to an immune attack, or permanently disabling them.
The rise in temperature also stimulates the white blood cells in our immune system resulting in macrophage activation. Activated macrophages will then chase down, attack, kill and engulf any invader.
Worth mentioning as a foot note is that because we are all built from the same cellular building blocks, macrophages will recycle about 95% of the virus into new immune cells (killing them to strengthen us).
The other 5% is cellular debris and will be detoxified naturally.
Toxicology studies of GcMAF
The performed pre‐clinical toxicology studies of human Gc globulin in mice, rats, guinea pigs, rabbits and Shetland ponies showed no toxic effects. In beagle dogs receiving a daily dose of 20 mg/kg Gc globulin intravenous for 14 days, clinical as well as histological immunological reactions caused by production of antibodies against human Gc globulin and immune complex formation were observed.
Future studies will hopefully show whether administration of Gc globulin to patients with severe tissue injuries such as trauma, liver failure and sepsis will be able to reduce the patient’s risk of developing hypercoagulation, shock and multiple organ failure.
Safety Pharmacology, Toxicology and Pharmacokinetic Assessment of Human Gc Globulin: Vitamin D Binding Protein – Pihl, Joergensen, Santoni-Rugiu, Leifsson, Hansen, Laursen, Houen: Basic & Clinical Pharmacology & Toxicology, 2010, Vol 107, pp 853-60.
If cancer, after the end of the first week of GcMAF you may notice the immune system has begun to attack tumours; at the end of three weeks it will be attacking at full strength, but you may not be aware of this.
The tumours should swell slightly initially as the immune system inflames and attacks them. Markers will rise initially as the tumours break up. If prostate cancer, GcMAF initially causes PSA numbers to rise for 2-3 months for the same reason.
If you are a responder, stage 4 or terminal cancer is not necessarily a bar to success.
But by comparison with chemotherapy or radiation treatments, the side effects are trivial.
If HIV, the IRIS disease may cause you to get worse before you get better. We don’t do well here, because the viruses conceal themselves with biofilms and block the VDR.
In 30% the diseases fight the immune system back rather as IRIS does in HIV, but not as bad. Nutrition is really important. You need the fully blown caveman diet of meat, fish vegetables and lipids. If you are on processed food, vegan, vegetarian or fast food diets, you are unlikely to make progress.
Occasionally there is initial pro-inflammatory response with worsening of asthma-like symptoms; it is the best indicator of an M1 shift. That is activation of pro-inflammatory macrophages that do the job of fighting viruses and disease. Although unwelcomed, this is the best indication that GcMAF is doing its job and it will eventually clear the body of the disease.
If in brain cancer you get headaches after taking GcMAF for just over a week, this may be intercranial pressure, which is serious. Treat with mannitol and diuretics (steroids / cortizone as a last resort.) Reduce the dose to 0.05 ml. Contact us immediately – we can put you in touch with a doctor who specialises in this.
GcMAF needs 8 weeks to begin to reduce tumour mass – after that, your symptoms should be receding.
With the above exceptions, and as a general rule of thumb, if the average participant is capable of a 40 minute brisk walk in the sunshine each day, even if they are terminal stage 4 and a high responder, they should have no difficulty surviving the war, and typically will, at most, occasionally experience the symptoms of a fever – hot flushes and tiredness.
Please note these are our experiences so far; we are not doctors and you should take GcMAF under the supervision of a doctor. If at any time you feel you want to discontinue Gc MAF, please do so. We do NOT suggest you abandon any life saving treatment. If you are on rigorous medications, always confer with your specialist and ask for progress reports before making any changes to your treatment regime
If you are taking GcMAF, please check this often for new information, as new data comes in.